KRAS, NRAS,BRAF mutation testing Doctors Abroad — Page 2

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Dr. Auala Hubert chairs the Gastrointestinal Cancer Center at Hadassah Medical Center. He uses KRAS, NRAS, and BRAF mutation testing to guide advanced cancer therapies.

• Holds specialist certifications in both medical oncology and radiotherapy
• Performs HIPEC – delivers heated chemotherapy directly into the abdominal cavity
• Member of the Israel Society of Clinical Oncology committee for gastrointestinal cancer
• Uses CyberKnife and Brachytherapy for precise tumor targeting
• Qualified in USMLE standards for medical practice

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Professor Eckhart Weidmann heads the hematology department at Nordwest Clinic. KRAS, NRAS, and BRAF mutation testing helps him determine precise therapy for blood disorders.

• Specializes in treating complex blood cancers and non-Hodgkin lymphoma
• Leads a dedicated department at a major German academic hospital
• Focuses on targeted therapies based on genetic mutation profiles
• Member of the German Society of Hematology and Medical Oncology (DGHO)

Prof. Beni Boursi is a gastrointestinal oncology specialist at Sheba Medical Center. He uses KRAS, NRAS, and BRAF mutation testing for targeted therapy planning.

• Trained in oncology at the University of Pennsylvania and MD Anderson Cancer Center
• Academic scholar at the Perelman School of Medicine in the United States
• Published research on drug responses in patients with BRAF V600 mutations
• Member of the Israeli Association of Clinical Oncology and Radiotherapy
• Researches microbiome interactions to improve how patients respond to cancer treatments

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Elnur Sahibov is a specialist in radiation oncology at Emsey Hospital. He provides expertise in oncology services including KRAS, NRAS, and BRAF mutation testing.

• Trained at Marmara University Faculty of Medicine in radiation oncology
• Completed medical specialization between 2012 and 2016
• Graduated from the English-language medical program at Marmara University
• Practices at Emsey Hospital, a private multi-specialty center in Turkey

Dr. Chaitainya Borde has handled more than 30,000 PET scans at HCG Manavata Cancer Centre. This experience supports precise KRAS, NRAS, and BRAF mutation testing for cancer patients.

• Specializes in nuclear medicine – provides detailed imaging for accurate diagnosis
• Expert in all PET-CT scans for tracking cancer growth
• Published medical papers on advanced imaging and therapy
• Experienced in radioiodine and Lu-177 RN therapies for cancer
• Treated 1,000+ thyroid cancer patients using specialized nuclear services

Dr. Raj Nagarkar has performed 50,000+ cancer surgeries. He leads HCG Manavata Cancer Centre, where KRAS, NRAS, and BRAF mutation testing guides surgical planning.

• Completed surgical oncology residency at Tata Memorial Hospital in Mumbai
• Member of the Royal College of Surgeons of Edinburgh
• Participated in over 200 Phase 1–3 clinical trials
• Professor for DNB Superspecialty Surgical Oncology – training future cancer surgeons
• Treats complex cases of liver, pancreatic, and colorectal cancers

Dr. Shaunak Valame is a medical oncologist at HCG Manavata Cancer Centre. He specializes in molecular oncology to guide KRAS, NRAS, and BRAF mutation testing for targeted therapy.

• Earned a DNB in Medical Oncology from the prestigious Indraprastha Apollo Hospital
• Presented stomach cancer research at the ASCO Gastrointestinal Cancer Symposium in San Francisco
• Member of the American Society of Clinical Oncology (ASCO)
• Former lecturer for the International Winter School of Oncology at AIIMS Bhopal
• Provides precision treatment for lung, breast, and gastrointestinal cancers

Dr. Lalit Banswal has performed 10,000 major surgeries. He uses KRAS, NRAS, and BRAF mutation testing to guide surgical treatment for gastrointestinal cancers.

• Fellowship-trained in surgical oncology at Tata Medical Centre in Kolkata
• Serves as Assistant Professor at the State Cancer Institute
• Specializes in robotic and laparoscopic surgery for colon and rectal cancers
• Experienced lead investigator for clinical research in gastrointestinal oncology
• Member of the surgical oncology team at HCG Manavata Cancer Centre

Dr. Antonio Cubillo Gracián pioneered the first liquid biopsy program in Spain. He uses genetic data to guide KRAS, NRAS, and BRAF mutation testing for targeted therapy.

• Heads the Medical Oncology Service at Hospital Universitario HM Sanchinarro
• Directs postgraduate research at HM CIOCC, a leading Spanish cancer center
• Uses molecular markers like EGFR and ALK to design personalized cancer treatment plans
• Leads clinical trials for new cancer therapies through the Start Madrid program
• Member of the teacher faculty at USP CEU medical school

Professor Kayihan Engin is the Director of Oncological Sciences at Medicana Bursa Hospital. He manages gastrointestinal tumor cases where KRAS, NRAS, and BRAF mutation testing is essential for treatment planning.

• Completed a post-doctoral fellowship at Thomas Jefferson University in the USA
• Former Coordinator of Oncological Sciences at the Anadolu Medical Center
• Expert in gastrointestinal tumors including colorectal, esophageal, and liver cancers
• Conducted advanced research at the National Cancer Institute in Bethesda
• Served as Chairman of Radiation Oncology at Uludağ University Medical College

Dr. Shruti Kate heads the oncology department at HCG Manavata Cancer Centre. She previously served as a consultant at the prestigious Tata Memorial Hospital.

• Specializes in solid tumors and pediatric cancers requiring KRAS, NRAS, and BRAF mutation testing
• Presented lung cancer research at the 2018 World Conference on Lung Cancer in Toronto
• Won a travel award from the International Association for the Study of Lung Cancer
• Member of the American Society of Clinical Oncology and the European Society for Medical Oncology
• Expert in using immunotherapy and metronomic therapy for advanced cancer stages